Leishmaniasis cutánea: una mirada a la clínica, diagnóstico y tratamiento de esta enigmática enfermedad

• Serrano Coll, H. ^[1] ; Ana Pilar Ramos ^[2] ; Cardona Castro, N. ^[1] ; Llanos Cuentas, A. ^[2]
  1. [1] Universidad CES

     Universidad CES

     Colombia

     
  2. [2] Universidad Peruana Cayetano Heredia

     Universidad Peruana Cayetano Heredia

     Perú

     
• Localización: Piel: Formación continua en dermatología, ISSN 0213-9251, Vol. 36, Nº. 5 (Mayo), 2021, págs. 317-324
• Idioma: español
• DOI: 10.1016/j.piel.2020.06.012
• Títulos paralelos:
  • Cutaneous leishmaniasis: A view to the clinic, diagnostic, and treatment of this enigmatic disease
• Enlaces
  • Texto Completo Ejemplar
• Referencias bibliográficas
  • De Vries HJC, Reedijk SH, Schallig HDFH. Cutaneous leishmaniasis: recent developments in diagnosis and management. Am J Clin Dermatol. 2015;16(2):99–109.
  • Mahdy MAK, Al-Mekhlafi AM, Abdul-Ghani R, et al. First molecular characterization of Leishmania species causing visceral leishmaniasis among...
  • Steverding D. The history of leishmaniasis. Parasit Vectors. 2017;10(1):82.
  • David CV, Craft N. Cutaneous and mucocutaneous leishmaniasis. Dermatol Ther. 2009;22(6):491–502.
  • Aronson N, Herwaldt BL, Libman M, et al. Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases...
  • Bilgic-Temel A, Murrell DF, Uzun S. Cutaneous leishmaniasis: a neglected disfiguring disease for women. Int J Womens Dermatol. 2019;5(3):158–165.
  • Pires CAA, Pereira NG, Moreira AG, et al. Cutaneous leishmaniasis mimicking cutaneous lymphoma. IDCases. 2019;17: e00580.
  • Kevric I, Cappel MA, Keeling JH. New world and old world leishmania infections: a practical review. Dermatol Clin. 2015;33 (3):579–593.
  • Goldman L, Schafer A. Goldman-Cecil Tratado de Medicina Interna. 25a ed. Elsevier; 2017.
  • Torres-Guerrero E, Quintanilla-Cedillo MR, Ruiz-Esmenjaud J, Arenas R. Leishmaniasis: a review. F1000Research. 2017;6:750.
  • Rozman C, Cardellach F. Medicina Interna Farreras Rozman. España: Elsevier; 2016.
  • Bailey MS, Lockwood DNJ. Cutaneous leishmaniasis. Clin Dermatol. 2007;25(2):203–211.
  • Gangneux J-P, Sauzet S, Donnard S, et al. Recurrent American cutaneous leishmaniasis. Emerg Infect Dis. 2007;13(9): 1436–1438.
  • Grevelink SA, Lerner EA. Leishmaniasis. J Am Acad Dermatol. 1996;34(2 Pt 1):257–272.
  • Llanos-Cuentas Valencia B, Petersen C. Neuroparasitology and Tropical Neurology: Chapter 13. Neurological Manifestations of Human Leishmaniasis....
  • Membrive NA, Kazuma FJ, Silveira TGV, Teixeira JJV, ReinholdCastro KR, Teodoro U. Disseminated cutaneous leishmaniasis caused by Leishmania...
  • Machado GU, Prates FV, Machado PRL. Disseminated leishmaniasis: clinical, pathogenic, and therapeutic aspects. An Bras Dermatol. 2019;94(1):9–16.
  • Turetz ML, Machado PR, Ko AI, et al. Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil....
  • Hashiguchi Y, Gomez EL, Kato H, Martini LR, Velez LN, Uezato H. Diffuse and disseminated cutaneous leishmaniasis: clinical cases experienced...
  • Mokni M. Leishmaniosis cutáneas. EMC - Dermatología. 2016;50 (3):1–12.
  • Chaudhary RG, Bilimoria FE, Katare SK. Diffuse cutaneous leishmaniasis: co-infection with human immunodeficiency virus (HIV). Indian J Dermatol...
  • Schallig HDFH, Hu RVP, Kent AD, et al. Evaluation of point of care tests for the diagnosis of cutaneous leishmaniasis in Suriname. BMC Infect...
  • Kellerman R, Rakel D. Current Therapy. Elsevier; 2020.
  • Chouihi E, Amri F, Bouslimi N, et al. Cultures on NNN medium for the diagnosis of leishmaniasis. Pathol Biol (Paris). 2009;57(3): 219–224.
  • Boggild AK, Miranda-Verastegui C, Espinosa D, et al. Evaluation of a microculture method for isolation of Leishmania parasites from cutaneous...
  • Pagheh A, Fakhar M, Mesgarian F, Gholami S, Ahmadpour E. An improved microculture method for diagnosis of cutaneous leishmaniasis. J Parasit...
  • Ministerio de Salud-Colombia. Guía para la atención clínica integral del paciente con leishmaniasis; 2010.
  • González K, Diaz R, Ferreira AF, et al. Histopathological characteristics of cutaneous lesions caused by Leishmania Viannia panamensis in...
  • Sundharkrishnan L, North JP. Histopathologic features of cutaneous leishmaniasis and use of CD1a staining for amastigotes in old world and...
  • Ferrufino-Schmidt MC, Bravo F, Valencia BM, Llanos-Cuentas A, Boggild AK, LeBoit PE. Is CD1a useful for leishmaniasis diagnosis in the New...
  • Braz LMA. Tegumentary leishmaniasis diagnosis: what happened with MST (Montenegro Skin Test) in Brazil? Rev Inst Med Trop Sao Paulo. 2019;61:e17.
  • Antonio L de F, Fagundes A, Oliveira RVC, et al. Montenegro skin test and age of skin lesion as predictors of treatment failure in cutaneous...
  • Mouttaki T, Morales-Yuste M, Merino-Espinosa G, et al. Molecular diagnosis of cutaneous leishmaniasis and identification of the causative...
  • de Paiva-Cavalcanti M, de Morais RCS, Pessoa-E-Silva R, et al. Leishmaniases diagnosis: an update on the use of immunological and molecular...
  • Galluzzi L, Ceccarelli M, Diotallevi A, Menotta M, Magnani M. Real-time PCR applications for diagnosis of leishmaniasis. Parasit Vectors....
  • Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev. 2006;19(1):111–126.
  • Frézard F, Demicheli C, Ribeiro RR. Pentavalent antimonials: new perspectives for old drugs. Mol Basel Switz. 2009;14(7): 2317–2336.
  • Haldar AK, Sen P, Roy S. Use of antimony in the treatment of leishmaniasis: current status and future directions. Mol Biol Int. 2011;2011:571242.
  • PAHO, WHO. Leishmaniasis in the Americas treatment recommendations; 2015.
  • Lindoso JAL, Costa JML, Queiroz IT, Goto H. Review of the current treatments for leishmaniases. Res Rep Trop Med. 2012; 3:69–77.
  • Machado PR, Ampuero J, Guimarães LH, et al. Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil:...
  • Pinto-Martinez AK, Rodriguez-Durán J, Serrano-Martin X, Hernandez-Rodriguez V, Benaim G. Mechanism of action of miltefosine on Leishmania...
  • McGwire BS, Satoskar AR. Leishmaniasis: clinical syndromes and treatment. QJ. Mon J Assoc Physicians. 2014;107(1):7–14.
  • Dorlo TPC, Huitema ADR, Beijnen JH, de Vries PJ. Optimal dosing of miltefosine in children and adults with visceral leishmaniasis. Antimicrob...
  • Guery R, Henry B, Martin-Blondel G, et al. Liposomal amphotericin B in travelers with cutaneous and mucocutaneous leishmaniasis: not a panacea....
  • Sundar S, Chakravarty J. Liposomal amphotericin B and leishmaniasis: dose and response. J Glob Infect Dis. 2010;2(2): 159–166.
  • Solomon M, Baum S, Barzilai A, Scope A, Trau H, Schwartz E. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous...
  • Wortmann G, Zapor M, Ressner R, et al. Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis. Am J Trop Med Hyg. 2010;83(5):1028–1033.
  • Buates S, Matlashewski G. Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S28463: efficacy and mode of action....
  • Arevalo I, Tulliano G, Quispe A, et al. Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis....
  • Sundar S, Chakravarty J. An update on pharmacotherapy for leishmaniasis. Expert Opin Pharmacother. 2015;16(2):237–252.
  • Brito G, Dourado M, Polari L, et al. Clinical and immunological outcome in cutaneous leishmaniasis patients treated with pentoxifylline. Am...
  • Valencia BM, Miller D, Witzig RS, Boggild AK, Llanos-Cuentas A. Novel low-cost thermotherapy for cutaneous leishmaniasis in Peru. PLoS Negl...
  • Cardona-Arias JA, Vélez ID, López-Carvajal L. Efficacy of thermotherapy to treat cutaneous leishmaniasis: a metaanalysis of controlled clinical...